TSVT

2seventy bio
TSVT

Overview Fund Activity
Delisted

TSVT was delisted on the 13th of May, 2025.

Back to rankings

148 hedge funds and large institutions have $505M invested in 2seventy bio in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 22 closing their positions.

Holders
148
Holders Change
+3
Holders Change %
+2.07%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
25
Increased
61
Reduced
30
Closed
22
Calls
$1.16M
Puts
$407K
Net Calls
+$748K
Net Calls Change
+$456K

Top Buyers

1
APM
1
Avidity Partners Management
Texas
$13.6M
2
KCM
2
Kynam Capital Management
New Jersey
$49.5M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$12.9M
4
BlackRock
4
BlackRock
New York
$41.8M
5
Millennium Management
5
Millennium Management
New York
$29.3M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$2.07M
2
Balyasny Asset Management
2
Balyasny Asset Management
Illinois
$0
3
ITP
3
Iron Triangle Partners
Connecticut
$0
4
NM
4
Newtyn Management
New York
$7.47M
5
AG
5
Artal Group
Luxembourg
$0
Name Market Value Shares Shares
Change 		Shares
Change %
KCM
1
Kynam Capital Management
New Jersey
$49.5M 4,890,706 +1,151,734 +31%
BlackRock
2
BlackRock
New York
$41.8M 4,135,184 +974,661 +31%
Vanguard Group
3
Vanguard Group
Pennsylvania
$35.2M 3,477,674 +573,640 +20%
State Street
4
State Street
Massachusetts
$31M 3,060,206 -87,183 -3%
Millennium Management
5
Millennium Management
New York
$29.3M 2,895,476 +952,858 +49%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$29.1M 2,879,922 +110,480 +4%
BBA
7
Baker Bros. Advisors
New York
$25.3M 2,497,526 – –
O
8
OrbiMed
New York
$24.2M 2,391,628 – –
CC
9
Casdin Capital
New York
$20.5M 2,023,913 – –
Goldman Sachs
10
Goldman Sachs
New York
$16.4M 1,624,252 -123,270 -7%
ECM
11
ExodusPoint Capital Management
New York
$14.7M 1,457,390 +428,350 +42%
BCLSI
12
Bain Capital Life Sciences Investors
Massachusetts
$14.3M 1,408,901 – –
APM
13
Avidity Partners Management
Texas
$13.6M 1,342,000 +1,342,000 New
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$12.9M 1,276,952 +1,065,673 +504%
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
$11.9M 1,172,214 -411,467 -26%
CS
16
Credit Suisse
Switzerland
$10.3M 1,020,953 +2,979 +0.3%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$9.95M 983,226 +241,754 +33%
CA
18
CHI Advisors
New York
$8.62M 852,007 -2,993 -0.4%
Morgan Stanley
19
Morgan Stanley
New York
$7.86M 777,121 -388,205 -33%
NM
20
Newtyn Management
New York
$7.47M 737,744 -767,256 -51%
CCP
21
Clough Capital Partners
Massachusetts
$5.35M 529,110 +280,500 +113%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$5.28M 521,264 +405,084 +349%
DCM
23
DAFNA Capital Management
California
$5.02M 496,416 +496,416 New
SAM
24
Sectoral Asset Management
Quebec, Canada
$4.68M 462,485 -13,515 -3%
BC
25
Boxer Capital
California
$4.65M 459,836 – –
1
2 3 4 5